Table 4

Observed (O) and estimated (E) values of proportion cured and treated, and age standardized disability-adjusted life years (DALYs) per 100,000 population, by cancer in Norway in 2008 derived from observed estimates of the proportion cured and proportion treated, versus expected values derived from models
Cancer sites Proportion cured (%) Proportion treated (%) DALYsa
O E O E O E
Lip oral cavity 39 33 91 77 46 45
Nasopharynx 39 35 91 81 3 3
Other pharynx 39 39 91 91 32 32
Oesophagus 11 10 52 46 80 79
Stomach 21 34 46 72 149 153
Colorectum 56 50 90 81 658 644
Liver 10 10 30b 30b 48 48
Gallbladder 16 38 34 79 34 34
Pancreas 6 5 27b 27b 248 248
Larynx 66 48 87 63 21 20
Lung 12 10 17 14 864 860
Melanoma of skin 80 76 95 90 181 180
Kaposi Sarcoma c 0 0 0 0 0 0
Breast 76 63 98 81 609 569
Cervix uteri 74 59 87 70 109 101
Corpus uteri 80 71 95 85 88 84
Ovary 35 30 83 72 155 153
Prostate 69 64 79 73 362 351
Testis 96 96 99 99 43 43
Kidney 47 46 80 79 108 108
Bladder 67 62 94 87 105 104
Brain, nervous system 64 26 83 34 282 272
Thyroid 89 89 95 95 11 11
Hodgkin lymphoma 86 90 91 95 11 11
Non-Hodgkin lymphoma 40 37 74 69 134 132
Multiple myeloma 37 34 68 62 66 66
Leukaemia 51 35 47 32 153 152

aNot discounted with equal age weight.

bObserved values were used to estimate DALY because inadequate fit of estimated values.

cIncidence and mortality in Norway from Kaposi Sarcoma was 0.

Soerjomataram et al.

Soerjomataram et al. BMC Medical Research Methodology 2012 12:125   doi:10.1186/1471-2288-12-125

Open Data